复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
复星医药(600196) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入2,939,338.541,951,443.18942,032.284,106,719.593,091,188.90
营业收入2,939,338.541,951,443.18942,032.284,106,719.593,091,188.90
二、营业总成本2,841,559.561,890,436.25913,034.223,939,751.152,936,281.28
营业成本1,522,546.241,012,346.51492,029.602,136,557.401,588,959.96
营业税金及附加24,094.9618,474.829,642.8931,404.2023,382.89
销售费用626,928.40421,106.30212,584.87867,976.38659,221.97
管理费用306,735.64202,810.8897,313.33428,325.73314,456.36
财务费用88,302.6064,031.5227,718.26111,051.8085,456.47
研发费用272,951.72171,666.2273,745.26364,435.65264,803.63
资产减值损失----------
公允价值变动收益-37,510.65-4,859.67-28,174.46-11,593.94-10,624.58
投资收益309,536.03212,017.67128,138.17210,460.74149,876.28
其中:对联营企业和合营企业的投资收益140,085.8392,966.1438,577.58164,383.88121,465.23
汇兑收益----------
三、营业利润390,676.54276,120.84135,877.12424,510.39310,758.88
加:营业外收入1,799.101,054.40334.445,889.303,456.79
减:营业外支出8,741.295,327.081,457.3713,471.537,059.08
其中:非流动资产处置损失----------
四、利润总额383,734.35271,848.16134,754.20416,928.17307,156.59
减:所得税费用78,125.1561,827.1040,597.5765,684.1355,304.82
五、净利润305,609.20210,021.0694,156.63351,244.04251,851.76
归属于母公司所有者的净利润252,329.35170,196.7876,475.78276,988.66201,064.24
少数股东损益53,279.8439,824.2817,680.8574,255.3850,787.53
六、每股收益
基本每股收益(元/股)0.95000.64000.29001.04000.7500
稀释每股收益(元/股)0.95000.64000.29001.04000.7500
七、其他综合收益-38,522.97-3,265.93-11,047.154,314.23-21,392.73
八、综合收益总额267,086.22206,755.1383,109.47355,558.26230,459.03
归属于母公司所有者的综合收益总额224,246.28165,985.7765,201.53275,365.74183,339.47
归属于少数股东的综合收益总额42,839.9440,769.3617,907.9480,192.5247,119.56
下载全部历史数据到excel中 返回页顶